Spanish researchers dig through medical records to see how kidney drug performs in real life
NCT ID NCT07450820
Summary
This study looks back at existing medical records to understand how dapagliflozin, a medication already approved for chronic kidney disease, is used and how well it works in routine Spanish healthcare. Researchers will analyze data from over 14,000 patients to see how the drug affects kidney function decline, hospital visits, and healthcare costs. The goal is to learn about real-world treatment patterns and outcomes, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGMadrid, 28002, Spain
Conditions
Explore the condition pages connected to this study.